Janux Therapeutics

Janux is a clinical-stage company developing unique immunotherapies designed to generate tumor-specific immune responses to attack tumors without destroying a patient’s healthy tissue. We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full corporate rebrand that included a positioning platform, identity system and a new corporate website.